Wydział Chemii

Paulina Grocholska

Andrzej Konieczny

Zuzanna Kaźmierczak

Krystyna Dąbrowska

Karolina Panek-Laszczyńska

Marlena Kłak

Wojciech Witkiewicz

Zbigniew Szewczuk

Remigiusz Bąchor

2021

Molecules

26

7102/1-7102/14

10.3390/molecules26237102

Naukowa

Angielski

Artykuł

Early detection of any preeclampsia biomarkers may lower the risk of mortality, both for a mother and a child. Our study focuses on techniques for preeclampsia biomarker identification by comparing the results of a method using liquid chromatography mass spectrometry in multiple reaction monitoring mode (LC-MS/MS) with those by the enzyme-linked immunosorbent assay (ELISA) test, as well as by comparing the obtained results with clinical data. In the proposed LC-MS/MS method a tryptic digest peptide charge derivatization strategy was used as a tool for sensitive detection of podocin, i.e., a previously discovered preeclampsia biomarker present in urine samples from pregnant women. Urine samples from pregnant women with diagnosed preeclampsia were collected at different stages of pregnancy and from healthy subjects, and then were analyzed by ELISA test and the proposed method with LC-MS/MS. Charge derivatization of the ε amino group of C-terminal lysine residues in tryptic digests by 2,4,6-triphenylpyrylium salt was performed to increase the ionization efficiency in the LC-MS/MS mode. Podocin was identified at the early stage of pregnancy, while its detection using an ELISA test was not possible. The protocol for urine sample preparation was optimized. Our results show that the proposed method by LC-MS/MS in combination with peptide charge derivatization, provides an ultrasensitive tool for diagnosis of preeclampsia, and provides earlier detection than a clinical diagnosis or ELISA test. The proposed solution may revolutionize medical diagnostics.

podocin, podocyturia, preeclampsia, charge derivatization, LC-MS, MRM, ELISA

CC-BY

https://doi.org/10.3390/molecules26237102

http://www.mdpi.com/journal/metals